Oncogene - Table of Contents alert Volume 33 Issue 19

If you are unable to see the message below, click here to view.

Advertisement Your one-stop shop for Next Generation Sequencing Introducing our complete solution for NGS: DNA shearing: Shear DNA anywhere from 150kb to 75kb reliably Library preparation kits: Down to 50pg of input! Library prep automation: Unique, walk-away, hands-free, superb reproducibility Learn more  TABLE OF CONTENTS Volume 33, Issue 19 (May 2014) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement BRAND NEW: Discounts on lab equipment Exclusive prices and information - all in one place! Check our listings before you buy.  VISIT MARKETPLACE TODAY    Review Top Melanoma metastasis: new concepts and evolving paradigms W E Damsky, N Theodosakis and M Bosenberg Oncogene 2014 33: 2413-2422; advance online publication, June 3, 2013; 10.1038/onc.2013.194 Abstract | Full Text Original Articles Top Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression G Comito, E Giannoni, C P Segura, P Barcellos-de-Souza, M R Raspollini, G Baroni, M Lanciotti, S Serni and P Chiarugi Oncogene 2014 33: 2423-2431; advance online publication, June 3, 2013; 10.1038/onc.2013.191 Abstract | Full Text The oncogenic GLI transcription factors facilitate keratinocyte survival and transformation upon exposure to genotoxic agents W Harrison, B Cochrane, G Neill and M Philpott Oncogene 2014 33: 2432-2440; advance online publication, June 24, 2013; 10.1038/onc.2013.199 Abstract | Full Text Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin L Damiano, K M Stewart, N Cohet, J K Mouw, J N Lakins, J Debnath, D Reisman, J A Nickerson, A N Imbalzano and V M Weaver Oncogene 2014 33: 2441-2453; advance online publication, June 17, 2013; 10.1038/onc.2013.220 Abstract | Full Text EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis M Tanaka, H I Suzuki, J Shibahara, A Kunita, T Isagawa, A Yoshimi, M Kurokawa, K Miyazono, H Aburatani, S Ishikawa and M Fukayama Oncogene 2014 33: 2454-2463; advance online publication, June 10, 2013; 10.1038/onc.2013.204 Abstract | Full Text Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer H Zhang, C Yu, J Dai, J M Keller, A Hua, J L Sottnik, G Shelley, C L Hall, S I Park, Z Yao, J Zhang, L K McCauley and E T Keller Oncogene 2014 33: 2464-2477; advance online publication, June 10, 2013; 10.1038/onc.2013.203 Abstract | Full Text An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer I Garcia-Murillas, R Sharpe, A Pearson, J Campbell, R Natrajan, A Ashworth and N C Turner Oncogene 2014 33: 2478-2486; advance online publication, June 10, 2013; 10.1038/onc.2013.202 Abstract | Full Text Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation A L Manning, C Benes and N J Dyson Oncogene 2014 33: 2487-2494; advance online publication, June 24, 2013; 10.1038/onc.2013.201 Abstract | Full Text miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT C-J Kao, A Martiniez, X-B Shi, J Yang, C P Evans, A Dobi, R W deVere White and H-J Kung Oncogene 2014 33: 2495-2503; advance online publication, June 3, 2013; 10.1038/onc.2013.200 Abstract | Full Text EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180 H Feng, B Hu, K Vuori, J N Sarkaria, F B Furnari, W K Cavenee and S-Y Cheng Oncogene 2014 33: 2504-2512; advance online publication, June 3, 2013; 10.1038/onc.2013.198 Abstract | Full Text Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer A R Palla, D Piazzolla, M Abad, H Li, O Dominguez, H B Schonthaler, E F Wagner and M Serrano Oncogene 2014 33: 2513-2519; advance online publication, June 10, 2013; 10.1038/onc.2013.196 Abstract | Full Text The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling S Rosebeck, A O Rehman, I J Apel, D Kohrt, A Appert, M A O'Donnell, A T Ting, M-Q Du, M Baens, P C Lucas and L M McAllister-Lucas Oncogene 2014 33: 2520-2530; advance online publication, June 17, 2013; 10.1038/onc.2013.195 Abstract | Full Text A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF V Borgdorff, U Rix, G E Winter, M Gridling, A C Müller, F P Breitwieser, C Wagner, J Colinge, K L Bennett, G Superti-Furga and S N Wagner Oncogene 2014 33: 2531-2539; advance online publication, June 3, 2013; 10.1038/onc.2013.185 Abstract | Full Text Short Communication Top Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis C L Kennedy, M Najdovska, H Tye, L McLeod, L Yu, A Jarnicki, P S Bhathal, T Putoczki, M Ernst and B J Jenkins Oncogene 2014 33: 2540-2546; advance online publication, June 3, 2013; 10.1038/onc.2013.205 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.